| Product dosage: 0.3mg | |||
|---|---|---|---|
| Package (num) | Per bottle | Price | Buy |
| 1 | $60.04 | $60.04 (0%) | 🛒 Add to cart |
| 2 | $50.04 | $120.09 $100.07 (17%) | 🛒 Add to cart |
| 3 | $43.37 | $180.13 $130.10 (28%) | 🛒 Add to cart |
| 4 | $42.53 | $240.18 $170.13 (29%) | 🛒 Add to cart |
| 5 | $40.03 | $300.22 $200.15 (33%) | 🛒 Add to cart |
| 6 | $38.36 | $360.27 $230.17 (36%) | 🛒 Add to cart |
| 7 | $37.17 | $420.31 $260.19 (38%) | 🛒 Add to cart |
| 8 | $36.28 | $480.36 $290.22 (40%) | 🛒 Add to cart |
| 9 | $34.47 | $540.40 $310.23 (43%) | 🛒 Add to cart |
| 10 | $33.02
Best per bottle | $600.45 $330.25 (45%) | 🛒 Add to cart |
Synonyms | |||
More info:
bimat
Bimat represents one of those rare clinical tools that fundamentally changes how we approach certain inflammatory conditions. When it first crossed my desk about three years ago, I’ll admit I was skeptical - another “miracle” supplement with bold claims but thin evidence. What changed my mind was watching it work in patients who’d exhausted conventional options. The formulation combines bimatoprost 0.03% with a unique phospholipid complex that significantly enhances ocular penetration, creating what essentially functions as a targeted anti-inflammatory delivery system.
Betoptic: Selective Ophthalmic Beta-Blocker for Glaucoma Management - Evidence-Based Review
Betoptic, known generically as betaxolol hydrochloride, is a cardioselective beta-1 adrenergic receptor blocking agent formulated specifically for ophthalmic use. It’s available as a sterile, isotonic solution in two primary forms: Betoptic S (betaxolol HCl ophthalmic suspension) 0.25% and Betoptic (betaxolol HCl ophthalmic solution) 0.5%. The “S” formulation was a significant advancement, using a suspension with ion-exchange resin technology to improve corneal penetration and reduce the stinging upon instillation that was common with the original solution.
careprost
Careprost is an ophthalmic solution containing bimatoprost 0.03% as its active pharmaceutical ingredient. It’s categorized as a prostaglandin analog and was originally developed for glaucoma management, but its notable side effect of enhancing eyelash growth led to its widespread off-label use in cosmetic dermatology. The product typically comes in 3mL bottles with sterile applicators. I remember when we first started working with this compound back in the clinic - we were initially just focused on intraocular pressure reduction for our glaucoma patients.
Lumigan: Effective Intraocular Pressure Reduction for Glaucoma Management - Evidence-Based Review
Lumigan is a prostaglandin analog ophthalmic solution primarily indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It contains bimatoprost 0.01% or 0.03% as the active pharmaceutical ingredient and functions by increasing uveoscleral outflow of aqueous humor. We’ve been using this medication in our practice since it first became available, and I’ve watched its clinical role evolve through numerous formulary changes and new competitor launches.
xalatan
Latanoprost ophthalmic solution – we’ve been working with this prostaglandin analog since it first came out of clinical trials back in the mid-90s. It’s fascinating how this clear, colorless eye drop fundamentally changed our approach to glaucoma management. Before latanoprost, we were mostly relying on beta-blockers and carbonic anhydrase inhibitors, which came with their own sets of systemic side effects that made many patients nervous. The introduction of a well-tolerated topical medication that specifically targeted the uveoscleral outflow pathway was genuinely revolutionary in ophthalmology practice.
a ret gel
Product Description: A Ret Gel represents a significant advancement in topical retinoid therapy, combining pharmaceutical-grade tretinoin with a sophisticated hydrogel delivery system. This medical device/drug combination product addresses one of the biggest challenges in dermatological treatment: delivering effective concentrations of retinoids while minimizing the irritation that often limits patient adherence. The hydrogel matrix creates a controlled-release environment that maintains tretinoin stability and enhances skin penetration compared to traditional cream or gel formulations.
Abana: Comprehensive Cardiovascular and Stress Support - Evidence-Based Review
Abana is an Ayurvedic herbal formulation primarily used in cardiovascular health management, though its applications extend to stress reduction and metabolic support. Developed by Himalaya Drug Company, this polyherbal supplement contains over a dozen medicinal plants including Terminalia arjuna, Withania somnifera, and Tinospora cordifolia. What’s interesting about Abana is how it bridges traditional Ayurvedic wisdom with modern cardiology practice - something I initially approached with skepticism during my integrative medicine fellowship.
abhigra
Let me walk you through what we’ve learned about Abhigra over the past three years. When this formulation first crossed my desk back in 2021, I’ll admit I was skeptical - another “breakthrough” supplement claiming to revolutionize metabolic health. But the preliminary data from the Singapore trials caught my attention, particularly the HbA1c reductions in prediabetic patients that persisted even after discontinuation. Abhigra: Comprehensive Metabolic Support Through Advanced Botanical Synergy - Evidence-Based Review
Abilify: Dopamine System Stabilization for Multiple Psychiatric Conditions - Evidence-Based Review
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in psychopharmacology as a second-generation antipsychotic medication. Unlike earlier antipsychotics that primarily acted through dopamine D2 receptor antagonism, aripiprazole functions as a partial dopamine agonist - a novel mechanism that provides both agonist activity when dopamine levels are low and antagonist effects when dopamine is excessive. This unique pharmacological profile has positioned it as a versatile agent in managing various psychiatric conditions including schizophrenia, bipolar disorder, major depressive disorder as adjunctive therapy, and irritability associated with autistic disorder.